ロード中...
The impact of induction therapy with three doses of infliximab on deep histological healing in paediatric patients with active Crohn’s disease
INTRODUCTION: The clinical efficacy of infliximab (IFX) for induction of remission in both adults and children with active Crohn’s disease (CD) has been well documented. Recently, so-called “deep remission” defined as mucosal healing has become the ultimate endpoint of the most recent therapeutic ad...
保存先:
| 出版年: | Prz Gastroenterol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Termedia Publishing House
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5047967/ https://ncbi.nlm.nih.gov/pubmed/27713779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pg.2016.57753 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|